Financials
- Market Capitalization 3.72 B
- Employee 1 184
- Founded 2015
- CEO Christian Behrenbruch
- Website www.telixpharma.com
- Headquarter Australia
- FIGI BBG01N69K900
- Industry Биотехнологии
Общий доход
Чистая прибыль
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты
Related tickers
| # | Название | Цена | 24ч % | 7д % | 1М % | 1Г % | Капитализация | Последние 7 дней | |
|---|---|---|---|---|---|---|---|---|---|
| 1528 | NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 33.88 USD | +1.80% | -6.43% | +8.66% | -6.59% | 3.96 B USD | ||
| 1533 | CPRX Catalyst Pharmaceuticals, Inc. - Common Stock | 31.48 USD | 0.00% | -0.03% | +0.38% | +48.42% | 3.85 B USD | ||
| 1556 | DNLI Denali Therapeutics Inc. - Common Stock | 23.11 USD | -12.73% | -12.23% | +5.72% | +42.92% | 3.67 B USD | ||
| 1573 | GPCR Structure Therapeutics Inc - American Depositary Shares | 51.71 USD | +0.14% | -8.02% | +20.26% | +93.38% | 3.68 B USD |